These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 27273067)

  • 1. A systematic review and meta-analysis of randomized controlled trials of the effect of barley β-glucan on LDL-C, non-HDL-C and apoB for cardiovascular disease risk reduction
    Ho HV; Sievenpiper JL; Zurbau A; Blanco Mejia S; Jovanovski E; Au-Yeung F; Jenkins AL; Vuksan V
    Eur J Clin Nutr; 2016 Nov; 70(11):1239-1245. PubMed ID: 27273067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of oat β-glucan on LDL-cholesterol, non-HDL-cholesterol and apoB for CVD risk reduction: a systematic review and meta-analysis of randomised-controlled trials.
    Ho HV; Sievenpiper JL; Zurbau A; Blanco Mejia S; Jovanovski E; Au-Yeung F; Jenkins AL; Vuksan V
    Br J Nutr; 2016 Oct; 116(8):1369-1382. PubMed ID: 27724985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review and meta-analysis of randomized controlled trials of the effect of konjac glucomannan, a viscous soluble fiber, on LDL cholesterol and the new lipid targets non-HDL cholesterol and apolipoprotein B.
    Ho HVT; Jovanovski E; Zurbau A; Blanco Mejia S; Sievenpiper JL; Au-Yeung F; Jenkins AL; Duvnjak L; Leiter L; Vuksan V
    Am J Clin Nutr; 2017 May; 105(5):1239-1247. PubMed ID: 28356275
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of psyllium (Plantago ovata) fiber on LDL cholesterol and alternative lipid targets, non-HDL cholesterol and apolipoprotein B: a systematic review and meta-analysis of randomized controlled trials.
    Jovanovski E; Yashpal S; Komishon A; Zurbau A; Blanco Mejia S; Ho HVT; Li D; Sievenpiper J; Duvnjak L; Vuksan V
    Am J Clin Nutr; 2018 Nov; 108(5):922-932. PubMed ID: 30239559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials.
    Whitehead A; Beck EJ; Tosh S; Wolever TM
    Am J Clin Nutr; 2014 Dec; 100(6):1413-21. PubMed ID: 25411276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of the effects of beta-glucan consumption on serum lipid profile and glucose level in hypercholesterolemic subjects.
    Zhu X; Sun X; Wang M; Zhang C; Cao Y; Mo G; Liang J; Zhu S
    Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):714-23. PubMed ID: 26026211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of viscous soluble fiber on blood pressure: A systematic review and meta-analysis of randomized controlled trials.
    Khan K; Jovanovski E; Ho HVT; Marques ACR; Zurbau A; Mejia SB; Sievenpiper JL; Vuksan V
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):3-13. PubMed ID: 29153856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Fructose on Established Lipid Targets: A Systematic Review and Meta-Analysis of Controlled Feeding Trials.
    Chiavaroli L; de Souza RJ; Ha V; Cozma AI; Mirrahimi A; Wang DD; Yu M; Carleton AJ; Di Buono M; Jenkins AL; Leiter LA; Wolever TM; Beyene J; Kendall CW; Jenkins DJ; Sievenpiper JL
    J Am Heart Assoc; 2015 Sep; 4(9):e001700. PubMed ID: 26358358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portfolio Dietary Pattern and Cardiovascular Disease: A Systematic Review and Meta-analysis of Controlled Trials.
    Chiavaroli L; Nishi SK; Khan TA; Braunstein CR; Glenn AJ; Mejia SB; Rahelić D; Kahleová H; Salas-Salvadó J; Jenkins DJA; Kendall CWC; Sievenpiper JL
    Prog Cardiovasc Dis; 2018; 61(1):43-53. PubMed ID: 29807048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-glucan from barley and its lipid-lowering capacity: a meta-analysis of randomized, controlled trials.
    AbuMweis SS; Jew S; Ames NP
    Eur J Clin Nutr; 2010 Dec; 64(12):1472-80. PubMed ID: 20924392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of concentrated barley beta-glucan on blood lipids in a population of hypercholesterolaemic men and women.
    Keenan JM; Goulson M; Shamliyan T; Knutson N; Kolberg L; Curry L
    Br J Nutr; 2007 Jun; 97(6):1162-8. PubMed ID: 17445284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.
    Boekholdt SM; Arsenault BJ; Mora S; Pedersen TR; LaRosa JC; Nestel PJ; Simes RJ; Durrington P; Hitman GA; Welch KM; DeMicco DA; Zwinderman AH; Clearfield MB; Downs JR; Tonkin AM; Colhoun HM; Gotto AM; Ridker PM; Kastelein JJ
    JAMA; 2012 Mar; 307(12):1302-9. PubMed ID: 22453571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of low-fat diet on serum lipids in premenopausal and postmenopausal women: a meta-analysis of randomized controlled trials.
    Wu L; Ma D; Walton-Moss B; He Z
    Menopause; 2014 Jan; 21(1):89-99. PubMed ID: 23736858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.
    Robinson JG; Wang S; Jacobson TA
    Am J Cardiol; 2012 Nov; 110(10):1468-76. PubMed ID: 22906895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.
    Farnier M; Guyton JR; Jensen E; Polis AB; Johnson-Levonas AO; Brudi P
    Atherosclerosis; 2013 Aug; 229(2):415-22. PubMed ID: 23880197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL-C: role as a risk modifier.
    Barter P
    Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of the effect of β-glucan intake on blood cholesterol and glucose levels.
    Tiwari U; Cummins E
    Nutrition; 2011 Oct; 27(10):1008-16. PubMed ID: 21470820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
    Elshazly MB; Nicholls SJ; Nissen SE; St John J; Martin SS; Jones SR; Quispe R; Stegman B; Kapadia SR; Tuzcu EM; Puri R
    Am J Cardiol; 2016 Sep; 118(5):647-55. PubMed ID: 27392507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat beta-glucan-containing ready meal.
    Biörklund M; Holm J; Onning G
    Ann Nutr Metab; 2008; 52(2):83-90. PubMed ID: 18334815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.